| Expression pattern: |
UP |
| Associated gene: |
ADAM17 |
| Associated microRNA: |
miR-338-3p |
| Biological function: |
Promotes gastric cancer cell proliferation, tumor growth, migration, invasion, progression and metastasis; knockdown inhibits GC cell growth, migration and invasion. |
| Molecular mechanism: |
circ_0051620 acts as a sponge for miR-338-3p and upregulates ADAM17 expression, thereby promoting gastric cancer progression. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
S
M
|
| Validation methods: |
RNase R Treatment; RT-qPCR; RNA-seq; Microarray; FISH / smFISH; Clinical Sample Validation; Luciferase Reporter Assay; Transfection; CCK8; Transwell Assay; Wound Healing Assay; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
Overexpression is associated with progress, poor prognosis and TNM stage in gastric cancer. |
| Description: |
circ_0051620 is up-regulated in gastric cancer tissues and cell lines and its high expression is associated with TNM stage and poor prognosis. Functionally, circ_0051620 promotes GC cell proliferation, migration and invasion by sponging miR-338-3p and increasing ADAM17 expression, suggesting the circ_0051620/miR-338-3p/ADAM17 axis as a potential therapeutic target. |
| Confidence score: |
0.7566 |